Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Other Non-Current Liabilities (2020 - 2025)

Agilon Health (AGL) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $52.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities fell 31.27% year-over-year to $52.3 million, compared with a TTM value of $52.3 million through Dec 2025, down 31.27%, and an annual FY2025 reading of $52.3 million, down 31.27% over the prior year.
  • Other Non-Current Liabilities was $52.3 million for Q4 2025 at Agilon Health, up from $50.3 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $94.3 million in Q4 2021 and bottomed at $2.8 million in Q3 2021.
  • Average Other Non-Current Liabilities over 5 years is $59.4 million, with a median of $70.9 million recorded in 2023.
  • Peak annual rise in Other Non-Current Liabilities hit 3031.31% in 2022, while the deepest fall reached 45.21% in 2022.
  • Year by year, Other Non-Current Liabilities stood at $94.3 million in 2021, then fell by 11.68% to $83.3 million in 2022, then decreased by 15.49% to $70.4 million in 2023, then grew by 8.16% to $76.1 million in 2024, then plummeted by 31.27% to $52.3 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for AGL at $52.3 million in Q4 2025, $50.3 million in Q3 2025, and $54.9 million in Q2 2025.